Kymera Therapeutics (KYMR)
Develops oral protein degraders for immunology and partnered oncology programs.
$113.82
vs last close−8.24 (−6.75%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 41 days
EPS estimate
−$1.25
Revenue estimate
$3.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26Apr '26Aug '26Nov '26
Reported−$0.88−$0.82−$0.95−$0.90−$0.97−$0.71−$0.62Pending
Estimate−$0.76−$0.92−$0.83−$0.71−$0.78−$0.89−$0.71−$1.25
Surprise−15.8%+10.9%−14.5%−26.8%−23.8%+20.2%+13.0%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26Apr '26Aug '26Nov '26
Reported$7.4M$22.1M$11.5M$2.8M$2.9M$34.4M$65.0MPending
Estimate$16.7M$12.4M$17.1M$14.5M$15.0M$8.3M$32.8M$3.3M
Surprise−55.7%+78.5%−33.0%−80.9%−80.9%+315.7%+98.3%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$1.49 | — | — |
| Sep 2028 | −$1.53 | — | — |
| Jun 2028 | −$1.50 | — | — |
| Mar 2028 | −$1.45 | — | — |
| Dec 2027 | −$1.30 | — | — |
| Sep 2027 | −$1.25 | — | — |
| Jun 2027 | −$1.27 | — | — |
| Mar 2027 | −$1.24 | — | — |
| Dec 2026 | −$1.26 | — | — |
| Nov 2026 | −$1.25 | — | — |
| Aug 2026 | −$0.71 | −$0.62 | +13.0% |
| Apr 2026 | −$0.89 | −$0.71 | +20.2% |
| Feb 2026 | −$0.78 | −$0.97 | −23.8% |
| Nov 2025 | −$0.71 | −$0.90 | −26.8% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Jun 2020 | |||
| Aug 2020 | |||
| Dec 2019 | |||
| Sep 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$1.49 | — | — | $10.0M | — | — | — |
| Sep 2028 | −$1.53 | — | — | $10.0M | — | — | — |
| Jun 2028 | −$1.50 | — | — | $10.0M | — | — | — |
| Mar 2028 | −$1.45 | — | — | $10.0M | — | — | — |
| Dec 2027 | −$1.30 | — | — | $10.1M | — | — | — |
| Sep 2027 | −$1.25 | — | — | $12.0M | — | — | — |
| Jun 2027 | −$1.27 | — | — | $10.0M | — | — | — |
| Mar 2027 | −$1.24 | — | — | $8.6M | — | — | — |
| Dec 2026 | −$1.26 | — | — | $4.5M | — | — | — |
| Nov 3, 2026 | −$1.25 | — | — | $3.3M | — | — | — |
| Aug 5, 2026 | −$0.71 | −$0.62 | +13.0% | $32.8M | $65.0M | +98.3% | +1.0% |
| Apr 30, 2026 | −$0.89 | −$0.71 | +20.2% | $8.3M | $34.4M | +315.7% | −0.5% |
| Feb 26, 2026 | −$0.78 | −$0.97 | −23.8% | $15.0M | $2.9M | −80.9% | +4.8% |
| Nov 4, 2025 | −$0.71 | −$0.90 | −26.8% | $14.5M | $2.8M | −80.9% | +0.3% |
| Aug 11, 2025 | |||||||
| May 9, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Oct 31, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 2, 2024 | |||||||
| Feb 22, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 4, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 3, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 6, 2021 | |||||||
| May 6, 2021 | |||||||
| Mar 11, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Aug 21, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 |